GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $29,000 | +107.1% | 430 | 0.0% | 0.00% | +200.0% |
| Q2 2022 | $14,000 | +55.6% | 430 | +62.3% | 0.00% | 0.0% |
| Q1 2022 | $9,000 | -30.8% | 265 | -39.8% | 0.00% | 0.0% |
| Q4 2021 | $13,000 | +8.3% | 440 | -3.3% | 0.00% | 0.0% |
| Q3 2021 | $12,000 | -25.0% | 455 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $16,000 | +33.3% | 455 | +56.9% | 0.00% | 0.0% |
| Q1 2021 | $12,000 | -7.7% | 290 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $13,000 | -13.3% | 290 | +5.5% | 0.00% | 0.0% |
| Q3 2020 | $15,000 | -11.8% | 275 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $17,000 | +21.4% | 275 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $14,000 | -36.4% | 275 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $22,000 | +175.0% | 275 | +57.1% | 0.00% | 0.0% |
| Q3 2019 | $8,000 | -11.1% | 175 | 0.0% | 0.00% | +100.0% |
| Q2 2019 | $9,000 | – | 175 | – | 0.00% | – |
| Q1 2019 | $0 | – | 0 | – | 0.00% | – |
| Q4 2018 | $0 | – | 0 | – | 0.00% | – |
| Q3 2018 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 177,414 | $14,103,000 | 11.50% |
| Fernwood Investment Management, LLC | 258,012 | $20,509,000 | 9.81% |
| Perceptive Advisors | 5,865,726 | $466,266,000 | 9.26% |
| ArchPoint Investors | 186,756 | $14,845,000 | 4.54% |
| STANSBERRY ASSET MANAGEMENT, LLC | 115,638 | $9,192,000 | 3.74% |
| Camber Capital Management LP | 730,000 | $58,028,000 | 2.95% |
| Profit Investment Management, LLC | 46,873 | $3,726,000 | 2.50% |
| Casdin Capital, LLC | 300,000 | $23,847,000 | 2.19% |
| SECTORAL ASSET MANAGEMENT INC | 174,594 | $13,878,000 | 2.07% |
| Corriente Advisors, LLC | 40,000 | $3,180,000 | 1.71% |